Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Effect of taVNS on the Prognosis of Patients Undergoing Pancreatoduodenectomy

NCT: NCT06786923 · COMPLETED

NCT IDNCT06786923
StatusCOMPLETED
Start Date2025-01-17
Completion2025-10-31
SponsorAffiliated Hospital of Nantong University (OTHER)
First posted
Last updated

Brief Summary

To explore the effects of transcutaneous auricular vagus nerve stimulation (taVNS) during the perioperative period on the incidence of delayed gastric emptying after pancreatoduodenectomy and its possible mechanisms.

Frequently Asked Questions

What is The Effect of taVNS on the Prognosis of Patients Undergoing Pancreatoduodenectomy?

The Effect of taVNS on the Prognosis of Patients Undergoing Pancreatoduodenectomy is a clinical trial registered under NCT06786923. Current status: COMPLETED.

What is the status of NCT06786923?

The current status of NCT06786923 (The Effect of taVNS on the Prognosis of Patients Undergoing Pancreatoduodenectomy) is: COMPLETED.

When did The Effect of taVNS on the Prognosis of Patients Undergoing Pancreatoduodenectomy start?

The Effect of taVNS on the Prognosis of Patients Undergoing Pancreatoduodenectomy started on 2025-01-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑